Uniphar (DUB:UPR) Other Current Payables: €8 Mil (As of Dec. 2025)


DUB:UPR Uniphar PLC DUB:UPR
79 GF Score
Price €4.78
GF Value €3.64
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Uniphar Other Current Payables?

Uniphar DUB:UPR +2.69% 79 Other Current Payables is €8 Mil as of Dec. 2025. GuruFocus rates DUB:UPR with a GF Score™ of 79/100 and a GF Value™ of €3.64 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Uniphar's Other Current Payables for the quarter that ended in Dec. 2025 was €8 Mil.

Uniphar's quarterly Other Current Payables declined from Dec. 2024 (€11 Mil) to Jun. 2025 (€0 Mil) but then increased from Jun. 2025 (€0 Mil) to Dec. 2025 (€8 Mil).

Uniphar's annual Other Current Payables increased from Dec. 2023 (€8 Mil) to Dec. 2024 (€11 Mil) but then declined from Dec. 2024 (€11 Mil) to Dec. 2025 (€8 Mil).

Uniphar Other Current Payables Related Terms

Uniphar Other Current Payables Historical Data

* Premium members only.

The historical data trend for Uniphar's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uniphar Other Current Payables Chart

Uniphar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.56 5.40 7.93 10.87 7.88

Uniphar Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.93 0.00 10.87 0.00 7.88
DUB:UPR
79GF Score
Uniphar PLC DUB:UPR
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Uniphar Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of €8 Mil mean?
Uniphar (DUB:UPR) has a Other Current Payables of €8 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Uniphar and its competitors.
Is Uniphar's Other Current Payables too high?
Uniphar's current Other Current Payables is €8 Mil. Overall, Uniphar has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Uniphar's Other Current Payables compare to MCK and CAH?
Uniphar's Other Current Payables of €8 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Distribution company?
A good Other Current Payables depends on the Medical Distribution industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Uniphar and its competitors. Uniphar's current Other Current Payables is €8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uniphar stock overvalued right now?
Based on GuruFocus' analysis, Uniphar (DUB:UPR) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.64, compared to a current price of €4.78 — trading 31.3% above its estimated fair value. The current Other Current Payables is €8 Mil. Uniphar's overall GF Score™ is 79/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Uniphar (DUB:UPR), the current Other Current Payables is €8 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Uniphar (DUB:UPR) Overvalued in 2026?

Based on GuruFocus' analysis, Uniphar stock appears to be overvalued. The current stock price of €4.78 is trading 31.3% above its estimated GF Value™ of €3.64. GuruFocus considers Uniphar to be Significantly Overvalued.

Key valuation signals for DUB:UPR:

  • Other Current Payables: €8 Mil
  • GF Value™: €3.64 vs. price of €4.78 (31.3% above fair value)
  • GF Score™: 79/100 with 9 warning signs

No single metric tells the full story. See the DUB:UPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Uniphar Business Description

Other Exchanges UPR:UK0NR:Germany
Address 4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K
Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.
79GF Score

Get the complete analysis for DUB:UPR

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.78
Price
€3.64
GF Value